🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several experts said the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has taken down violative material and banned related hashtags and query recommendations. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.

After minutes of entering one group, a seller posted contact information, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Item Information and Costs

Within these groups, posts show dark colored parcels with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly significant health risks”.